Steve Jobs, CEO of Apple, is easing back into work after a nearly six-month medical leave. He will be working from home for a few days a week, for the first few weeks in order to maintain his health. During his absence, the pancreatic cancer survivor underwent a liver transplant.
His representatives continually assured the public that Jobs was involved in strategic decisions about the direction Apple would take during his leave. Apple stocks have surged and dipped in the past in response to news and Jobs’ health, but during this absence the lack of information caused investors to remain relatively steady. Industry analysts suspect that investors are becoming used to the idea of other executives besides Jobs at the helm.